Financials in USD. Standardized financial statements.
A compact view of how Park Ha Biological Technology Co., Ltd. Ordinary Shares turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue? | $2.52M | $2.38M | $2.46M | $1.92M | $931,036 |
| Revenue Growth? | +6.0% | -3.1% | +28.1% | +106.2% | 0.0% |
| Cost of Revenue? | $142,526 | $195,336 | $310,989 | $509,162 | $311,162 |
| Gross Profit? | $2.38M | $2.19M | $2.15M | $1.41M | $619,874 |
| Gross Margin? | +94.4% | +91.8% | +87.4% | +73.5% | +66.6% |
| Operating Expenses? | $26.53M | $1.39M | $967,559 | $1.21M | $1.12M |
| Operating Income? | -$24.15M | $793,714 | $1.18M | $197,024 | -$500,976 |
| EBITDA? | -$23.97M | $816,107 | $1.20M | $220,695 | -$444,758 |
| Income Before Tax | -$24.08M | $793,421 | $1.18M | $190,010 | -$484,958 |
| Income Tax Expense | $280,646 | $314,860 | $329,527 | -$1,288 | $0 |
| Net Income? | -$24.36M | $478,561 | $852,042 | $191,298 | -$484,958 |
| EPS? | $-41.38 | $0.92 | $1.63 | $0.36 | $-0.93 |
| Diluted EPS? | $-41.38 | $0.92 | $1.63 | $0.36 | $-0.93 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality